================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
October 20, 2004
(Date of report)
CARACO PHARMACEUTICAL LABORATORIES, LTD.
----------------------------------------
(Exact name of registrant as specified in its charter)
Michigan 0-24676 38-2505723
---------------------------------- ------------------------- -----------------------
(State or other jurisdiction of (Commission file number) (I.R.S. employer
incorporation) identification no.)
1150 Elijah McCoy Drive, Detroit, Michigan 48202
------------------------------------------------
(Address of principal executive offices)
(313) 871-8400
--------------
(Registrant's telephone number, including area code)
Not Applicable
--------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 140.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION AND ITEM 7.01.
REGULATION FD DISCLOSURE
On October 20, 2004, registrant announced its results of operations for
the quarter ended September 30, 2004, as set forth in the press release included
as Exhibit 99.1 hereto, which is incorporated herein by reference.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
c) Exhibits.
Exhibit No. Description
99.1 Press Release of Caraco Pharmaceutical
Laboratories, Ltd., dated October 20, 2004
announcing third quarter of 2004 results of
operations
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, registrant
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
CARACO PHARMACEUTICAL LABORATORIES, LTD.
Date: October 20, 2004 By: /s/ Jitendra N. Doshi
-----------------------------------
Jitendra N. Doshi
Chief Executive Officer
3
EXHIBIT INDEX
Exhibit No. Description
99.1 Press Release of Caraco Pharmaceutical Laboratories, Ltd.,
dated October 20, 2004 announcing third quarter of 2004
results of operations.
4